KAELI EDMONDS: Open Payments
NPI 1528439668 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,151 in 45 payments from 13 companies in 2025. Trend: 2023 $876 · 2024 $893 · 2025 $1,151
Food & beverage: $1,151
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $414 |
| Alexion Pharmaceuticals, Inc. | 1 | $118 |
| OPKO Pharmaceuticals, LLC | 7 | $113 |
| Calliditas Therapeutics US Inc. | 4 | $105 |
| Otsuka America Pharmaceutical, Inc. | 5 | $99 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Vifor Pharma, Inc. | 2 | $52 |
| Medtronic, Inc. | 1 | $48 |
| Travere Therapeutics, Inc. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
Products named: Fabhalta, ULTOMIRIS, RAYALDEE, TARPEYO, JYNARQUE, JARDIANCE, Veltassa, SYMPLICITY G3.
Industry payments across AL — which companies pay providers there.
